Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Statement re Offer for Subscription

10 Jan 2022 12:43

RNS Number : 9606X
Maven Income and Growth VCT 3 PLC
10 January 2022
 

Maven Income and Growth VCT 3 PLC and Maven Income and Growth VCT 4 PLC (the Companies)

 

Offers for Subscription - Early Investment Incentive

 

10 January 2022

 

On 20 September 2021, the Companies published a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription of new Ordinary Shares of 10p each (together the "Offers" and each an "Offer").

 

In the Prospectus, it was stated that all valid applications that were received (together with their relevant application monies) by the deadline of 12.00 noon on 28 January 2022 would be eligible to receive an Early Investment Incentive discount under the Offers. Existing Shareholders (and their spouses or partners) in any of the Maven VCTs, including the Companies, at the time the application was received would benefit from an enhanced rate of discount in recognition of their continued support for the Maven VCTs. The levels of discount to be applied would be:

 

· 1.5% of the application amount for Existing Shareholders; and

· 1.25% of the application amount for New Investors.

 

It was also stated that each Company could, in consultation with Maven Capital Partners UK LLP (Maven) and in their absolute discretion, extend the deadline by which applications must be received to be eligible for the Early Investment Incentive under its Offer.

 

The Board of each Company confirms that the deadline by which applications must be received to be eligible for the Early Investment Incentive under their Company's respective Offer has been extended until close of business on Wednesday 2 February 2022. Furthermore, it is anticipated that both Companies will make initial allotments of new Ordinary Shares under their respective Offers as soon as practicable after that date.

 

Further information

 

Any enquiries in respect of the Offers, or requests for copies of the Prospectus documents (available free of charge), should be directed to:

 

Maven Capital Partners UK LLP

Kintyre House

205 West George Street

Glasgow

G2 2LW

 

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Downloadable versions of the Prospectus documents are available from the Maven website at: www.mavencp.com/vctoffer.

Maven Capital Partners UK LLPSecretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFSFLIIILIF
Date   Source Headline
18th Nov 20115:12 pmRNSTransaction in Own Shares
16th Nov 20112:36 pmRNSTransaction in Own Shares
15th Nov 201111:41 amRNSTransaction in Own Shares
15th Nov 201111:31 amRNSDirector/PDMR Shareholding
11th Nov 20113:17 pmRNSTransaction in Own Shares
10th Nov 201111:20 amRNSDirector/PDMR Shareholding
4th Nov 20113:59 pmRNSTransaction in Own Shares
3rd Nov 20112:51 pmRNSTransaction in Own Shares
2nd Nov 20112:54 pmRNSTransaction in Own Shares
25th Oct 20115:36 pmRNSTransaction in Own Shares
21st Oct 201110:51 amRNSTransaction in Own Shares
20th Oct 201111:37 amRNSTransaction in Own Shares
19th Oct 201111:38 amRNSTransaction in Own Shares
18th Oct 20114:59 pmRNSTransaction in Own Shares
17th Oct 20113:22 pmRNSTransaction in Own Shares
12th Oct 20113:33 pmRNSInterim Management Statement
26th Aug 20114:56 pmRNSDirector/PDMR Shareholding
19th Jul 20112:02 pmRNSDirector/PDMR Shareholding
8th Jul 20114:02 pmRNSHalf Yearly Report
2nd Jun 201110:38 amRNSDirector/PDMR Shareholding
25th May 201110:30 amRNSAnnual Information Update
19th May 201111:42 amRNSDirector/PDMR Shareholding
5th May 201110:54 amRNSResult of AGM
5th May 201110:23 amRNSInterim Management Statement
4th May 20113:24 pmRNSIssue of Equity
14th Apr 20115:44 pmRNSDirector/PDMR Shareholding
6th Apr 20112:28 pmRNSDirector/PDMR Shareholding
6th Apr 20112:27 pmRNSDirector/PDMR Shareholding
6th Apr 20119:31 amRNSIssue of Equity
8th Mar 20119:42 amRNSDirector/PDMR Shareholding
8th Mar 20119:32 amRNSDirector/PDMR Shareholding
2nd Mar 20119:54 amRNSTotal Voting Rights
1st Mar 20114:01 pmRNSAnnual Financial Report
2nd Feb 20114:12 pmRNSIssue of Equity
18th Nov 20102:43 pmRNSDirector/PDMR Shareholding
18th Nov 20102:00 pmRNSStatement re Linked Offer for Subscription
18th Nov 20101:18 pmRNSTransaction in Own Shares
3rd Nov 201011:10 amRNSDirector/PDMR Shareholding
20th Oct 20103:58 pmRNSStatement re Cancellation of Share Premium Account
20th Oct 20103:58 pmRNSStatement re Cancellation of Share Premium Account
14th Oct 20103:02 pmRNSInterim Management Statement
1st Sep 20103:22 pmRNSResult of EGM
6th Aug 20102:26 pmRNSCirc re. cancellation of share premium
9th Jul 20104:37 pmRNSHalf Yearly Report
28th May 20104:21 pmRNSTransaction in Own Shares
20th May 20109:05 amRNSTransaction in Own Shares
12th May 20109:16 amRNSInterim Management Statement
10th May 201011:21 amRNSTotal Voting Rights
7th May 201011:58 amRNSTransaction in Own Shares
7th May 20109:35 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.